Before and After: Patient Cases in Onychomycosis

Slides:

Advertisements

Similar presentations

Welcome to A Day of Derm for GPs, thank you so much for joining us today in Ajax (you may want to add something related to the weather ie. Thank you fo.

Advertisements

Multimodal Management of Opioid-Induced Constipation

Understanding Treatment Goals for Patients With Onychomycosis

Chronic HCV Infection and CKD

Clinical Trials in IBD.

New Psoriasis Treatments

Psoriatic Arthritis.

This program will include a discussion of off-label treatment not approved by the FDA for use in the United States.

Why Gene Therapy for Hemophilia?

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Improving Survival in Glioblastoma Multiforme

5 Things NPs and PAs Need to Know About Tardive Dyskinesia

Long-Term Treatment of VTE: Case Studies

Pseudomonas Lung Infections in Cystic Fibrosis

Progression After Cancer Immunotherapy in Advanced NSCLC

Immune Reconstitution in MS:

Clues to a Diagnosis: A Focus on Light-Chain Amyloidosis

Ask the Onychomycosis Expert, Part 2

Ask the Onychomycosis Expert, Part 1

Why Treat Seborrheic Keratosis?

Improving Acne Outcomes

Case Challenges in Chronic Migraine

How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients

Updates in Management of Atopic Dermatitis From Real Patient Cases

Advances in Dry Eye.

Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.

Treating Transplant-Ineligible Patients With Multiple Myeloma

A Closer Look at Pemphigus Vulgaris: Clinical Challenges and Emerging Treatments.

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.

Treatment of Generalized Tonic-Clonic Seizures in the Modern Era

The Nurse View.

Optimizing Management of Advanced Bladder Cancer

A Frontline Clinician's Guide to Managing Opioid-Induced Constipation

Multidisciplinary Perspectives on Interstitial Lung Diseases

Nontuberculous Mycobacterial Lung Disease

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Management of CMV in HSCT Recipients

Evaluating Next-Generation BTK Inhibitors

Gene Therapy: Past, Present, and Future

Tackling Atopic Dermatitis

Ask the Experts.

Immunotherapy for cSCC

Optimizing Frontline Care for Older Patients With Multiple Myeloma

Pseudobulbar Affect or Psychiatric Condition?

Best Practices in the Clinical Management of Motor Symptoms Associated With Huntington Disease.

When Is Biologic Therapy Appropriate for HS?

Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.

Personalizing Management in the Care of Patients With Advanced Sarcoma

Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.

Getting to Grips With the Science of CGRP and Migraine

Long-Term Treatment of VTE: Case Studies

Guide to Atopic Dermatitis

Cancer-Associated Thrombosis

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

The Burden of Psoriasis:

Patient Questions and Expert Answers in Psoriasis:

The Psychiatrist's Role in Tardive Dyskinesia

Pregnancy in MS.

Incorporating Prostacyclins Into Practice

Program Goals Background: Anticoagulation in Patients With VTE.

Why New Treatments for Hyperhidrosis Should Be on Your Radar

The Psychiatrist's Role in Tardive Dyskinesia

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Diagnostic Criteria Migraine Without Aura

Ask the Psoriasis Expert

Presentation transcript:

Before and After: Patient Cases in Onychomycosis

This program will include a discussion of off-label treatment not approved by the FDA for use in the US

What Is Onychomycosis?

Clinical Signs of Onychomycosis

Risk Factors for Onychomycosis

Case 1

Onychomycosis and Diabetes

Treatment Options in Case 1

Case 2

Onychomycosis and Psoriasis

Differential Diagnosis for Onychomycosis

Diagnostic Tests for Onychomycosis

Why Not Treat Empirically?

Treatment Options in Case 2

Case 3

Treatment Options in Case 3

Why Treat Onychomycosis? It's an Infection

Guidance on Referrals

Oral and Topical Agents: Pros and Cons

Topical Treatments for Onychomycosis

Oral Treatments for Onychomycosis

Laser Therapy for Onychomycosis

Barriers to Effective Treatment of OM

Case 4

Patient Education for Ensuring Adherence

Recurrence of OM: Relapse vs Reinfection

Patient Education to Prevent Recurrence

What Is a Cured Nail?

Summary

Abbreviations